Part 3/10:
Despite over three decades of advocacy and research, there remains a glaring lack of a definitive cure for HIV. As treatments currently available manage the virus effectively, some voices within the medical community question the pharmaceutical industry's interest in pursuing a cure, suggesting that the existing model of lifelong, expensive treatment is more beneficial for profit motives than for patient outcomes.